rs10993994: Understanding the MSMB Prostate Cancer Risk Variant
The genetic variant rs10993994 is a single nucleotide polymorphism (SNP) located in the regulatory region of the MSMB gene. It has been consistently identified in genome-wide association studies as a marker associated with an increased risk of developing prostate cancer.
What each genotype means
Lower prostate cancer risk
This genotype is associated with a lower statistical risk of developing prostate cancer compared to those carrying the T allele. Research indicates that the C allele is the more common, non-risk variant in many populations. This finding is based on population-level associations and does not predict an individual's personal health outcome.
The C allele is generally more frequent than the T allele in most global populations, making the C/C genotype relatively common.
Intermediate prostate cancer risk
Carrying one copy of the T allele is associated with a moderate increase in the statistical risk of prostate cancer compared to the C/C genotype. This variant is located near the MSMB gene, which plays a role in prostate function. These results reflect population-wide trends and should not be interpreted as a medical diagnosis.
This heterozygous genotype is found at varying frequencies across different ancestral groups, reflecting the distribution of the T risk allele.
Increased prostate cancer risk
This genotype is associated with an increased statistical risk of developing prostate cancer, with some studies reporting an odds ratio of approximately 1.6. The T allele is considered the risk-associated variant at this location in the MSMB gene region. Please note that this is a statistical association observed in large studies and does not determine individual health status.
The T/T genotype is less common than the C/C genotype in many populations, though its frequency varies significantly by ancestry.
What is rs10993994?
A single nucleotide polymorphism, or SNP, is a variation at a single position in a DNA sequence among individuals. The variant rs10993994 is located on chromosome 10 at position 10q11. Specifically, it sits within the 5' untranslated region (UTR) of the MSMB gene. This region acts as a promoter, meaning it helps control how much of the MSMB protein is produced by the cell. Because this SNP is located in a regulatory area rather than the protein-coding sequence itself, it does not change the structure of the protein, but it can significantly influence the amount of protein expressed in prostate tissue. Researchers use this variant as a tag to study how genetic differences in this specific genomic neighborhood contribute to complex health traits.
The Role of the MSMB Gene
The MSMB gene encodes a protein called microseminoprotein-beta. This protein is secreted in high concentrations by the prostate gland and is found in seminal fluid. Research suggests that MSMB may function as a tumor suppressor in the prostate. Studies have observed that the expression of this protein is often significantly reduced or lost in prostate cancer tissue compared to healthy tissue. Because the rs10993994 variant is located in the promoter region of MSMB, the presence of the risk allele is associated with lower levels of MSMB protein expression. This reduction in a potential tumor suppressor is believed to be one of the biological mechanisms through which this genetic variant may contribute to an increased susceptibility to prostate cancer.
Research and Evidence Strength
The association between rs10993994 and prostate cancer is supported by multiple genome-wide association studies (GWAS). The evidence is considered moderate to strong, as the association has been replicated across diverse populations, including individuals of European and African ancestry. Statistical analysis indicates that the T allele of this SNP confers an increased risk of prostate cancer, with odds ratios typically reported around 1.16 to 1.3 per allele. While this variant is a well-documented risk factor, it is important to note that prostate cancer is a polygenic condition, meaning it is influenced by many different genetic variants, as well as environmental and lifestyle factors. Having the risk allele does not mean an individual will develop cancer, nor does the absence of the allele guarantee protection.
Population Frequency
The frequency of the rs10993994 risk allele varies significantly across different ancestral groups. In European populations, the risk allele frequency is generally reported to be between 30% and 40%. In contrast, the frequency is notably higher in men of African ancestry, where it can range from 70% to 80%. These differences in allele frequency highlight the importance of considering ancestry when interpreting genetic risk data. Because the variant is common in the general population, it is considered a low-penetrance risk factor, meaning it contributes a small amount of risk to a large number of people rather than acting as a high-risk mutation that causes disease on its own.
Interpreting Your Genetic Information
Information about your rs10993994 genotype is a tool for understanding your genetic predisposition, but it should not be used for self-diagnosis or medical decision-making. Genetic risk scores are complex and are best interpreted by healthcare professionals who can place them in the context of your personal and family medical history. If you are concerned about your risk for prostate cancer, the most effective action is to consult with a physician or a genetic counselor. They can provide guidance on appropriate screening schedules, such as prostate-specific antigen (PSA) testing or digital rectal exams, based on your overall risk profile. Never make changes to your health management or screening routine based solely on a single genetic variant result without professional medical advice.
How common is this variant?
The risk allele frequency is approximately 30-40% in European populations and 70-80% in populations of African ancestry.
Frequently asked questions
Does having the rs10993994 risk allele mean I will get prostate cancer?
No. This variant is a common genetic marker associated with a modest increase in risk, not a diagnostic test. Many people with the risk allele never develop prostate cancer, and many people without it do.
Should I get tested for this SNP?
Genetic testing for specific SNPs is generally not recommended for the general population. If you have concerns about your prostate cancer risk, speak with your doctor about standard clinical screening options.
Is rs10993994 the only gene involved in prostate cancer?
No. Prostate cancer is a complex, polygenic disease influenced by hundreds of genetic variants, as well as age, family history, and lifestyle factors. This SNP is only one small piece of a much larger genetic puzzle.
Can I change my genotype?
No, your genotype is determined at conception and cannot be changed. However, knowing your risk factors can help you and your doctor make informed decisions about your health and screening schedule.
Sources & further reading
Educational information only, last refreshed 10/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10993994?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
This variant (p.Asn843Ser) in the PPIP5K2 gene is associated with hereditary eye disease and altered kinase activity.
This exonic variant in PPIP5K2 is linked to hereditary eye disease and has been shown to reduce phosphatase activity in vitro.
This variant is associated with hereditary prostate cancer and has been designated as pathogenic in clinical databases.
This missense variant (p.Pro384Arg) is associated with familial natural short sleep (FNSS1), an autosomal dominant trait characterized by a reduced need for sleep.
This rare variant in the IFIH1 gene is associated with a protective effect against the development of Type 1 Diabetes.
Recently linked to local adaptation of immune responses in diverse ancestral groups.